Literature DB >> 9013993

Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice.

A Nakajima1, S Hirose, H Yagita, K Okumura.   

Abstract

Development of either Th1 or Th2 cell subsets has profound immunologic consequences, either pathogenic or protective, in several autoimmune diseases. However, it remains unclear which subset of Th cells plays a more critical role in lupus. In this study, we examined IL-4 and IL-12, which play decisive roles in the development of Th2 and Th1, respectively, in the IgG autoantibody production and development of lupus nephritis in NZB/W (B/W) F1 mice. Transfer of either IL-4- or IL-12-stimulated splenocytes from 5-mo-old B/W F1 mice into B/W F1 mice of the same age enhanced the production of IgG anti-dsDNA Ab. Consistently, administration of mAb against either IL-4 or IL-12 before the onset of lupus could inhibit the production of IgG anti-dsDNA Ab. However, only anti-IL-4 mAb was effective in preventing the onset of lupus nephritis. This discrepancy appeared to be explained by the differential effect on the production of IgG3-type autoantibody and TNF production. Interestingly, when combined, anti-IL-12 mAb abrogated the beneficial effect of anti-IL-4 mAb. These results indicate that both Th2 and Th1 contribute to the IgG autoantibody production, and IL-4 and IL-12 play key roles in the complexity of cytokine regulation in the pathogenesis of autoimmunity in lupus, but the former is more critical.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.

Authors:  Rama Devi Mittal; Parmeet Kaur Manchanda
Journal:  Immunogenetics       Date:  2007-01-04       Impact factor: 2.846

Review 3.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

4.  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus.

Authors:  Begum Horuluoglu; Defne Bayik; Neslihan Kayraklioglu; Emilie Goguet; Mariana J Kaplan; Dennis M Klinman
Journal:  J Autoimmun       Date:  2019-01-22       Impact factor: 7.094

5.  B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.

Authors:  Arpita Choudhury; Philip L Cohen; Robert A Eisenberg
Journal:  Clin Immunol       Date:  2010-04-08       Impact factor: 3.969

6.  A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.

Authors:  S Ono; D Shao; S Yamada; Y Yang; M Yamashita; T Hamaoka
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

7.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

8.  Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines.

Authors:  Y Tokano; S Morimoto; H Kaneko; H Amano; K Nozawa; Y Takasaki; H Hashimoto
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 9.  Application of cellular gene therapy for rheumatoid arthritis.

Authors:  Atsuo Nakajima
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.

Authors:  Kareem L Graham; Lowen Y Lee; John P Higgins; Lawrence Steinman; Paul J Utz; Peggy P Ho
Journal:  Autoimmunity       Date:  2010-03       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.